Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank33
3Y CAGR-15.6%
5Y CAGR-64.2%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-15.6%/yr
Annual compound
5Y CAGR
-64.2%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -25.8% |
| 2024 | 0.01 | -38.9% |
| 2023 | 0.02 | +32.6% |
| 2022 | 0.01 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 1.22 | - |
| 2019 | 0.00 | - |